4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-20-014846
Options or other derivatives
- Exec. VP, European Commercial acquired 82,393 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Daniell Richard · Exec. VP, European Commercial
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-28 | Grant or award : show line 1 in the form Restricted Share Units | +82,393 | 82,393 | D |
Loading xslF345X03/doc4.xml…